Hashizume Makoto
Kyushu University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hashizume Makoto.
Archive | 2012
Akahoshi Tomohiko; Tomikawa Morimasa; Kamori Masao; Tsutsumi Norifumi; Nagao Yoshihiro; Hashizume Makoto; Maehara Yoshihiko
Aim: Although endoscopic injection of cyanoacrylate (CA) is the only effective method for treating isolated fundal gastric variceal bleeding, the rebleeding rate is relatively high. This study investigated the efficacy of balloon‐occluded retrograde transvenous obliteration (B‐RTO) for management of isolated fundal gastric variceal bleeding.
Archive | 2012
Uehara Hideo; Akahoshi Tomohiko; Kawanaka Hirohumi; Hashimoto Naotaka; Nagao Yoshihiro; Tomikawa Morimasa; Taketomi Akinobu; Shirabe Ken; Hashizume Makoto; Maehara Yoshihiko
Aim: Splenectomy or partial splenic embolism has been reported to improve liver function in patients with hypersplenism and liver dysfunction. The aim of this study was to investigate the mechanism of improvement after splenectomy.
Magnetic Resonance Imaging | 2010
Matsuoka Yoshinori; Murata Masaharu; Huzisaki Yuri; Narahara Sayoko; Shinzato Nao; Hashizume Makoto
BACKGROUND AND AIMS Diagnosis of liver disease has improved because of progress in imaging technology. Among the imaging methods, magnetic resonance imaging (MRI) has the advantage of a lack of radiation exposure, but the basis of the method (imaging of hydrogen atoms in water molecules) makes it hard to detect changes in tissue or the location of the diseased tissue in the liver. The aims of this study are to develop new contrast media for visualization of functional changes in the liver and to check the effectiveness of the media. METHODS We developed a new molecular imaging contrast media that targets the asialoglycoprotein receptor (ASGP-R), a membrane protein that is specific to hepatocytes. We first checked the contrast media diameter and the cytotoxicity. Next, we examined the interaction of the media with ASGP-R through observation of fluorescein isothiocyanate (FITC)-labeled molecular imaging contrast media bound to normal hepatocellular ASGP-R using confocal laser scanning microscopy. Finally, we used MRI to observe hepatocyte interactions with the molecular imaging contrast media. RESULTS The contrast media forms a nanoparticle of about 30 nm diameter in aqueous solution and the cytotoxicity is low. In vitro, the media has high specificity for ASGP-R in normal rat hepatocyte RLN-8 cells and this interaction was blocked by lactose (which has a similar molecular structure to that of galactose) and by an anti-ASGP-R antibody. The contrast media markedly enhanced T1-weighted images in MRI of normal rat hepatocytes compared to the signal strength for rat liver cancer cells. CONCLUSIONS We have shown that our new contrast media for molecular imaging of hepatocytes by MRI is effective in vitro.
Archive | 2012
Fujie Masakatsu; Kobayashi Hiroshi; Tsukune Mariko; Ichiyanagi Ken; Ogasawara Nobuhiro; Cho Hiroshi; Hashizume Makoto; Ikeda Tetsuo; Akahoshi Tomohiko; Nakadate Ryu
Archive | 2010
Fujie Masakatsu; Okamoto Atsushi; Kawamura Kazuya; Kumasaka Yu; Nomura Mariko; Takasugi Shinichiro; Kenmochi Hajime; Hashizume Makoto; Iwamoto Yukie
Archive | 2014
Murata Masaharu; 村田 正治; Hashizume Makoto; 橋爪 誠
Journal of Japan Society of Computer Aided Surgery | 2007
Arata Jumpei; 荒田 純平; 高橋 弘樹; Takahashi Hiroki; 割澤 伸一; Warisawa Shinichi; 小西 晃造; Konishi Kozo; 田上 和夫; Tanoue Kazuo; 家入 里志; Ieiri Satoshi; 清水 周次; Shimizu Shuji; 中島 直樹; Nakashima Naoki; 岡村 耕二; Okamura Koji; Kim Young Soo; 橋爪 誠; Kim Sung Min; 光石 衛; Hahm Joon-Soo; Hashizume Makoto; Mitsuishi Mamoru
Archive | 2018
Nakadate Ryu; Kenmotsu Hajme; Hashizume Makoto; Fujita Hroyasu; Nagai Shunsuke; Kato Jro
Archive | 2018
Nakadate Ryu; Kenmotsu Hajme; Hashizume Makoto; Fujita Hroyasu; Nagai Shunsuke; Kato Jro
IEICE Technical Report; IEICE Tech. Rep. | 2018
Shimomura Tomoshige; Yokota Tatsuya; Chika Iwamoto; Ohuchida Kenoki; Hashizume Makoto; Hontani Hidekata